World Therapeutic Vaccines Market - Opportunities and Forecasts, 2017 - 2023

  • ID: 3773568
  • Report
  • Region: Global
  • Allied Analytics LLP
1 of 2
Therapeutic vaccines are provided to the body during treatment of specific diseases. This vaccine triggers and strengthens the immune response of the body to act against a disease. In 2011, the global therapeutic vaccines market was valued at $294 million. This vaccine has expanded the horizon of chronic disease treatment. However, there is a need to get a vaccine for specific disease to be approved by the FDA. Increasing cases of chronic diseases and need for effective treatment is acting as key driver for this market. Various pharmaceutical companies are working to develop novel vaccines for diseases such as lung cancer, breast cancer, Alzheimer, etc. However, these vaccine developments are in pipeline and yet to be commercialized.

Inefficient Research & development and reimbursement policies are primary factors restraining the market. Furthermore, as the market is in nascent stage, strict regulatory implications are also expected to deter growth. However, as the vaccine carries potential to treat many chronic diseases, these restraints would get weaker with time. This report delivers micro level analysis of the therapeutic vaccine market and its opportunities in various disease treatments.

Key market players profiled in this report include Affiris, Antigenics, Argos Therapeutics, Bavarian Nordic, Biovest International, Celldex Therapeutics, Cel-Sci, Celtic Pharma, Curevac And Cytos Biotechnology.


The report provides strategic analysis of the current market trend and delivers expected trends that would assist stakeholders to take strategic and actionable decisions
Present market quantitative scenario and estimations through 2013-2020
Analysis of the market factors in various geographic regions and help understand business opportunities
Identification of key investment pockets for various applications, services and geographies
Identification of key players and their business performance analysis based on strategies followed by them
Identification of key application segments based on future potential and growth prospects
Top factors affecting the market and analysis of probable changes in impact of those factors
Analysis and evaluation of market trends to provide deep-dive intelligence into every market segment
Competitive analysis based on strategies followed by key players to effectively plan and execute business plan
Micro level analysis based on application, service and geography



Addiction Vaccines

Cocaine Addiction Vaccines
Nicotine Addiction Vaccines

Autoimmune Disease Vaccines

Diabetes (Type 1)

Diamyd (RHGAD65)

Cancer Vaccines

Cancer vaccines in development
Cancer vaccines approved for use

Infectious Disease Vaccines

Other infectious disease vaccines (outside HIV)
Hepatitis C

Neurological disease vaccines

Parkinson’s disease vaccine
Other disease vaccines


Autologous vaccines
Allogeneic vaccines


North America
Asia Pacific

* This report will be delivered in 12 Business Days. *
Note: Product cover images may vary from those shown
2 of 2


3 of 2
Note: Product cover images may vary from those shown
Order Online - visit: